Shopping Cart
- Remove All
Your shopping cart is currently empty
THZ-P1-2 is a selective and potent PI5P4K inhibitor with anti-leukemic activity that acts by disrupting mitochondrial homeostasis and autophagy.THZ-P1-2 induces cell death and mitochondrial damage, and can be used in the study of leukemias.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $71 | In Stock | |
| 5 mg | $172 | In Stock | |
| 10 mg | $242 | In Stock | |
| 25 mg | $388 | In Stock | |
| 50 mg | $547 | In Stock | |
| 100 mg | $767 | In Stock | |
| 200 mg | $987 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $197 | In Stock |
| Description | THZ-P1-2 is a selective and potent PI5P4K inhibitor with anti-leukemic activity that acts by disrupting mitochondrial homeostasis and autophagy.THZ-P1-2 induces cell death and mitochondrial damage, and can be used in the study of leukemias. |
| In vitro | THZ-P1-2 (0.2-11.4 μM) exhibits approximately 75% inhibition of PI-4,5-P2 formation by PI5P4Kα and PI5P4Kγ and 50% inhibition by PI5P4Kβ at 0.7 μM[1]. THZ-P1-2 (10-100000 nM; 72 hours) demonstrates modest anti-proliferative activity across six AML/ALL cell lines, with IC50 values ranging from 0.87 to 3.95 μM[1]. Cell Proliferation Assay[1]Cell Line: THP1, SEMK2, OCI/AML-2, HL60, SKM1, NOMO1 cells. Concentration: 10-100000 nM. Incubation Time: 72 hours. Result: Anti-proliferative activity with IC50 values from 0.87 to 3.95 μM. |
| Molecular Weight | 531.61 |
| Formula | C31H29N7O2 |
| Cas No. | 2058075-45-7 |
| Smiles | CN(C)C\C=C\C(=O)Nc1ccc(cc1)C(=O)Nc1cccc(Nc2cc(ncn2)-c2c[nH]c3ccccc23)c1 |
| Color | Yellow |
| Appearance | Solid |
| Storage | keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (150.49 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (6.21 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.